| The Leu7Pro polymorphism of the signal peptide of neuropeptide Y (NPY) gene is associated with increased levels of inflammatory markers preceding vascular complications in patients with type 2 diabetes. | |
| | |
MedLine Citation:
|
PMID: 20691708 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
AIMS/HYPOTHESIS: The Leucine7 to Proline7 (Leu7Pro) polymorphism of the signal peptide of neuropeptide Y (NPY) increases risk for vascular complications in diabetes. Diabetes is associated with low-grade inflammation, which has an important role in the development of atherosclerosis. Currently, we followed diabetes patients to investigate, if the Pro7 allele is associated with the inflammation related to atherosclerosis. METHODS: In the 5-year follow-up, the genotyped, pair-matched type 2 diabetes patients (12 with the Pro7 allele and 19 without) were investigated using non-invasive ultrasound based methods to measure the development of atherosclerosis (intima media thickness=IMT) and endothelium-dependent (FMD) and -independent nitrate-mediated (NMD) vasodilatation. The development of diabetic complications was followed annually, and the concentrations of inflammatory markers and NPY in plasma were determined. RESULTS: Patients with the Pro7 had increased U-albumin/creatinine (p=0.037), E-selectin (p=0.016), fasting insulin (p=0.011) and HOMA index (p=0.013) but decreased serum amyloid P concentrations (p=0.021). Furthermore, men with the Pro7 had increased CRP (p=0.010) and NPY (p=0.026) concentrations. IMT and FMD were similar in all patients, however, NMD decreased more during the follow-up in the patients with the Pro7 (p=0.002). NPY correlated positively with bIMT [r 0.04 (SE 0.02), p=0.007] and E-selectin negatively with FMD [r -0.05 (S.E 0.02), p=0.039]. CONCLUSIONS/INTERPRETATIONS: Diabetes patients with the Pro7 allele display increased levels of inflammatory molecules and NPY in blood, preceding vascular wall thickening and impaired endothelial dilatation, especially in male patients. |
| | |
Authors:
|
U Jaakkola; T Kakko; H Seppälä; E Vainio-Jylhä; T Vahlberg; O T Raitakari; J Kallio |
Related Documents
:
|
15309208 - Insulin resistance, metabolic syndrome and vascular diseases: update on mechanistic lin... 20075438 - Fetuin-a is an independent determinant of change of aortic stiffness over 1 year in non... 18930728 - Cilostazol improves endothelial dysfunction by increasing endothelium-derived hyperpola... 15833798 - Tempol therapy attenuates medial smooth muscle cell apoptosis and neointima formation a... 15134308 - Small for gestational age (sga): endocrine and metabolic consequences and effects of gr... 16955208 - Low cumulative incidence of proliferative retinopathy in childhood-onset type 1 diabete... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2010-08-05 |
Journal Detail:
|
Title: Microvascular research Volume: 80 ISSN: 1095-9319 ISO Abbreviation: Microvasc. Res. Publication Date: 2010 Dec |
Date Detail:
|
Created Date: 2010-11-15 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0165035 Medline TA: Microvasc Res Country: United States |
Other Details:
|
Languages: eng Pagination: 433-9 Citation Subset: IM |
Copyright Information:
|
Copyright © 2010 Elsevier Inc. All rights reserved. |
Affiliation:
|
Centre for Biotechnology, University of Turku, Tykistökatu 6, Turku, Finland. ulriikka.jaakkola@utu.fi |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Tissue viability imaging for assessment of pharmacologically induced vasodilation and vasoconstricti...
Next Document: Live cell imaging of micronucleus formation and development.